Pantoprazole Sodium for Injection, 40mg per vial, Single-dose vial, Rx only, Mfd. in India for: Auromedics Pharma LLC 6 Wheeling Road, Dayton, NJ 08810, NDC 55150-202-00
Published February 15, 2017 · Recall initiated: December 16, 2016
Summary
FDA records drug Class III recall D-0470-2017, published February 15, 2017 and initiated December 16, 2016. Recalling firm: Aurobindo Pharma USA Inc; Status: Terminated; Reported quantity: 29800 vials; Lot: Lot #: CPO160028, Exp. June 2018. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Discoloration: Some vials were found to contain powder with a yellowish-brownish appearance.
What to do
Voluntary: Firm initiated · Letter
Get an email if PANTOPRAZOLE SODIUM has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- PANTOPRAZOLE SODIUM
- Manufacturer
- Aurobindo Pharma USA Inc
- Distributor
- Nationwide in US
- Lot
- Lot #: CPO160028, Exp. June 2018
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAPantoprazole Sodium in 0.9% Sodium Chloride Injection, 80 mg/100 mL (0.8 mg/mL) Single-Dose Infusion Bag inSeptember 9, 2026
- FDAPantoprazole Sodium, Delayed-Release Tablets, USP, 40 mg, 1000-count bottle, Rx only, Manufactured for: CamberApril 29, 2026
- FDAPantoprazole Sodium for Injection 40mg per vial, Single dose vials NDC 71839-122-01 Packaged as (a) 10September 20, 2023
- FDAPantoprazole Sodium Delayed Release Tablets USP 40mg, 1000-count bottles, Rx only, Manufactured for: CamberApril 19, 2023
- FDAPotassium Chloride Oral Solution, USP, 10%, 20 mEq per 15 mL, packaged in 15 mL unit dose cups (NDCFebruary 15, 2017
- FDAAripiprazole Tablets, 2 mg, 30-count bottle, Rx only, Manufactured by: Apotex Inc., Toronto, Ontario, Canada,February 15, 2017
Questions about this recall
Was Pantoprazole Sodium for Injection, 40mg per vial, Single-dose vial, Rx only, Mfd. in India for: Auromedics Pharma LLC 6 Wheeling Road, Dayton, NJ 08810, NDC 55150-202-00 recalled?
Yes. FDA published recall D-0470-2017 on February 15, 2017. Reported hazard: Discoloration: Some vials were found to contain powder with a yellowish-brownish appearance.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: PANTOPRAZOLE SODIUM.